Corrigendum: Identification of miR-342-5p/MDM4/p53 network in acute myeloid leukemia
- Sema Misir1*corresponding author
- Serap Ozer Yaman2,3
- Ceylan Hepokur1
- Osman Akidan4
- Yuksel Aliyazicioglu3
- Francisco J. Enguita5
- Mazhar Salim Al Zoubi6
- 11 Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Türkiye
- 22 Department of Medical Biochemistry, Trabzon Kanuni Health Practice and Research Hospital, Trabzon Faculty of Medicine, University of Health Sciences, Trabzon, Türkiye
- 33 Department of Medical Biochemistry, Faculty of Medicine, Karadeniz Technical University, Trabzon, Türkiye
- 44 Department of Hematology, Mengücek Gazi Education and Research Hospital, Erzincan, Türkiye
- 55 Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
- 66 Department of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan
Abstract
Keywords
In the published article, there was an error in the legend for Figures 2, 3 as published. The legends for Figures 2, 3 were placed in the wrong order. The legend for Figure 2 should be Figure 3, and the legend for Figure 3 should be Figure 2. The corrected legend appears below.
“FIGURE 2 | Prediction of miRNA targets from miRDB in HL-60 and KG-1 cells. (A) There are 119 predicted targets for hsa-miR-342–5p with expression level ≥5 in cell line HL-60. (B) There are 141 predicted targets for hsa-miR-342–5p with expression level ≥5 in cell line KG-1. In addition, thosewith a target scoregreater than 50 in all cells were selected. miR-342–5p and putative mRNAs and visualized using by Cytoscape software 3.8.”
“FIGURE 3 | (A) Receiver operating characteristic curve analysis of miR-342–5p expression levels in control and AML groups was determined using data from GSE51908. (B) The Kaplan–Meier survival curve of AML and Control groups. Survival analysis was performed using data from Bullinger et al. (2010).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Citation
Misir, S., et al. (2025). Corrigendum: Identification of miR-342-5p/MDM4/p53 network in acute myeloid leukemia. Frontiers in Cell Death, Volume 4. https://doi.org/
- Received
- Accepted
- Published
- Volume
- 4 - 2025
Copyright
Copyright © 2025 Misir, Yaman, Hepokur, Akidan, Aliyazicioglu, Enguita and Al Zoubi.
License: http://creativecommons.org/licenses/by/4.0/
*Correspondence: Sema Misir
Article metrics
- Views
- 0
- Downloads
- 0
- Citations
- 0
- Shares
- 0
